Inventor · disambiguated record
Roger G. Harrison
Also filed as: HARRISON JR ROGER G · HARRISON ROGER · HARRISON ROGER G · HARRISON ROGER GARRICK
26 granted patents·16 pending applications·437 citations·filing 1974–2025
96Inventor score
Top patents by PatentIndex Score
42 records- 0197US3965157APreparation of α-acetoxy aldehydes and ketonesLILLY INDUSTRIES LTD·Filed 1974·Granted Jun 22, 1976·51 cites·8 claims
- 0293US5989868AFusion protein systems designed to increase soluble cytoplasmic expression of heterologous proteins in esherichia coliUNIV OKLAHOMA·Filed 1998·Granted Nov 23, 1999·129 cites·24 claims
- 0391US4166123AAcylaminopyrazolesLILLY INDUSTRIES LTD·Filed 1976·Granted Aug 28, 1979·21 cites·26 claims
- 0489US4089962AAcylamino triazoles as antiasthmatic agentsLILLY INDUSTRIES LTD·Filed 1976·Granted May 16, 1978·17 cites·4 claims
- 0585US7807644B2Chimeric proteins with phosphatidylserine binding domainsUNIV OKLAHOMA STATE·Filed 2008·Granted Oct 5, 2010·5 cites·13 claims
- 0684US5910319AFluoxetine enteric pellets and methods for their preparation and useLILLY CO ELI·Filed 1997·Granted Jun 8, 1999·53 cites·39 claims
- 0781US6207420B1Fusion protein systems designed to increase soluble cytoplasmic expression of heterologous proteins in Escherichia coliUNIV OKLAHOMA·Filed 1999·Granted Mar 27, 2001·44 cites·24 claims
- 0880US8986701B2Enzyme prodrug cancer therapy selectively targeted to tumor vasculature and methods of production and use thereofUNIV OKLAHOMA·Filed 2012·Granted Mar 24, 2015·3 cites·6 claims
- 0979US11266637B2Formulations of tegavivint and related compoundsITERION THERAPEUTICS INC·Filed 2019·Granted Mar 8, 2022·3 cites·11 claims
- 1079US7393833B2Chimeric proteins with phosphatidylserine binding domainsUNIV OKLAHOMA·Filed 2006·Granted Jul 1, 2008·3 cites·8 claims
- 1178US9987241B2Enzyme conjugate and prodrug cancer therapyUNIV OKLAHOMA·Filed 2015·Granted Jun 5, 2018·3 cites·11 claims
- 1273US9504745B2Compositions and methods for cancer treatment using targeted carbon nanotubesUNIV OKLAHOMA·Filed 2013·Granted Nov 29, 2016·1 cites·25 claims
- 1372US4143047A2-sulfinyl and 2-sulfonyl oxazolesLILLY INDUSTRIES LTD·Filed 1977·Granted Mar 6, 1979·6 cites·3 claims
- 1471US12246010B2Formulations of tegavivint and related compoundsITERION THERAPEUTICS INC·Filed 2022·Granted Mar 11, 2025·0 cites·15 claims
- 1571US11446365B2Antimalarial enzyme conjugates, kits containing same, and methods of producing and using sameUNIV OKLAHOMA·Filed 2018·Granted Sep 20, 2022·1 cites·13 claims
- 1671US4956290ALarge scale process for the purification of alcohol oxidasePHILLIPS PETROLEUM CO·Filed 1989·Granted Sep 11, 1990·31 cites·19 claims
- 1770US2025099414A1Compositions and methods for treating triple-negative breast cancerUNIV OKLAHOMA·Filed 2024·Application pending·0 cites
- 1869US4252971AChromatographic processUPJOHN CO·Filed 1979·Granted Feb 24, 1981·9 cites·13 claims
- 1966US2025205212A1Formulations of tegavivint and related compoundsITERION THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2065US2009304666A1Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereofUNIV OKLAHOMA·Filed 2009·Application pending·0 cites
- 2164US2025352655A1Therapeutic annexin-drug conjugates and methods of useUNIV OKLAHOMA·Filed 2025·Application pending·0 cites
- 2263USRE39030EFluoxetine enteric pellets and methods for their preparation and useLILLY CO ELI·Filed 2002·Granted Mar 21, 2006·1 cites·75 claims
- 2360US8473611B1Referrer cache chainMEIER RICHARD E·Filed 2009·Granted Jun 25, 2013·4 cites·6 claims
- 2458US8518870B2Compositions and methods for cancer treatment using targeted carbon nanotubesHARRISON JR ROGER G·Filed 2009·Granted Aug 27, 2013·6 cites·16 claims
- 2558US4977140AInjectable sustained release formulationLILLY CO ELI·Filed 1989·Granted Dec 11, 1990·22 cites·7 claims
- 2657US5417903AManually operated, controlled dose pill pressHABLEY MEDICAL TECHNOLOGY CORP·Filed 1993·Granted May 23, 1995·11 cites·23 claims
- 2756US2009062785A1Compositions and methods for cancer treatment using targeted single-walled carbon nanotubesHARRISON JR ROGER G·Filed 2008·Application pending·0 cites
- 2855US2004214747A1Method for administering monomeric insulinFiled 2004·Application pending·0 cites
- 2953US2021340020A1Surface modifiers for preparing age-resistant inorganic saltsTHE SHEPHERD CHEMICAL COMPANY·Filed 2021·Application pending·0 cites
- 3051US2022395578A1Therapeutic annexin-drug conjugates and methods of useUNIV OKLAHOMA·Filed 2020·Application pending·0 cites
- 3150US4186204AAcylamino derivativesLILLY INDUSTRIES LTD·Filed 1979·Granted Jan 29, 1980·2 cites·24 claims
- 3249US12178889B2Gold nanoparticle-ligand conjugates and methods of useUNIV OKLAHOMA·Filed 2019·Granted Dec 31, 2024·0 cites·3 claims
- 3347US2007207158A1Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereofHARRISON ROGER G·Filed 2007·Application pending·0 cites
- 3446US2008227687A1Composition and method for cancer treatment using targeted single-walled carbon nanotubesHARRISON ROGER G·Filed 2008·Application pending·0 cites
- 3544US4256876AProcess for precipitating aminoglycosidesUPJOHN CO·Filed 1980·Granted Mar 17, 1981·4 cites·9 claims
- 3643US2011002978A1Enzyme prodrug cancer therapy selectively targeted to tumor cells or tumor vasculature and methods of production and use thereofHARRISON ROGER G·Filed 2010·Application pending·0 cites
- 3742US2013183354A1Compositions and methods for cancer treatment using targeted carbon nanotubesHARRISON JR ROGER G·Filed 2013·Application pending·0 cites
- 3842US2005036984A1Conjugate for the specific targeting of anticancer agents to cancer cells and production thereofFiled 2004·Application pending·0 cites
- 3941US4775659AInjectable semi-solid formulationsLILLY CO ELI·Filed 1985·Granted Oct 4, 1988·7 cites·5 claims
- 4030US2001007853A1Method for administering monomeric insulin analogsFiled 1999·Application pending·0 cites
- 4130US2001053761A1Method for administering aspb28-human insulinFiled 1999·Application pending·0 cites
- 4224US2017128489A1Organo-transition metal complexes for the treatment of viral infectionsBUSATH DAVID D·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →